Duke Cancer Institute: New Approach to Shutting Down Breast Cancer Recurrence Shows Promise in Mice
October 22, 2019
October 22, 2019
DURHAM, North Carolina, Oct. 22 -- Duke Cancer Institute issued the following news release:
* * *
- Drug shuts down a pathway tumor cells use to become resistant to hormone therapies
* * *
A new approach to treat advanced breast cancer shuts down the growth of cells that become resistant to standard hormone therapy, according to Duke Cancer Institute animal studies.
The research, which is likely to be tested in clinical trials with . . .
* * *
- Drug shuts down a pathway tumor cells use to become resistant to hormone therapies
* * *
A new approach to treat advanced breast cancer shuts down the growth of cells that become resistant to standard hormone therapy, according to Duke Cancer Institute animal studies.
The research, which is likely to be tested in clinical trials with . . .